Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple myeloma terminating in acute eosinophilic leukemia.

K Maeda, E J VanSlyck, D L VanDyke

    Cancer Genetics and Cytogenetics
    |March 1, 1985
    PubMed
    Summary

    Chemotherapy for multiple myeloma can rarely induce acute eosinophilic leukemia, a secondary malignancy. This case highlights a rare chemotherapy-induced leukemia with specific cytogenetic abnormalities.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Satellited chromosome 10 detected prenatally in a fetus and confirmed as mosaic in a parent.

    Prenatal diagnosis·1999
    Same author

    Bilateral Peter's anomaly in an infant with 49,XXXXY syndrome.

    Journal of pediatric ophthalmology and strabismus·1998
    Same author

    Effect of serotonergic agents on regional concentrations of somatostatin- and neuropeptide Y-like immunoreactivities in rat brain.

    Brain research·1992
    Same author

    [A study of Epstein-Barr virus-associated hemophagocytic syndrome successfully treated with VP16 and analysis of T cell receptor chain genes of the bone marrow cells].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·1992
    Same author

    Antitumor effect of triphenylethylene derivative (TAT-59) against human breast carcinoma xenografts in nude mice.

    Journal of surgical oncology·1992
    Same author

    Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatients.

    Biological psychiatry·1992

    Area of Science:

    • Hematology
    • Oncology
    • Cancer Research

    Background:

    • Multiple myeloma is a hematologic malignancy.
    • Melphalan is a chemotherapy agent used in multiple myeloma treatment.
    • Chemotherapy can sometimes lead to secondary malignancies.

    Observation:

    • A 71-year-old woman with multiple myeloma was treated with melphalan for 8 years.
    • She developed refractory anemia, progressing to acute eosinophilic leukemia.
    • This represents a rare chemotherapy-induced secondary leukemia.

    Findings:

    • The patient's acute eosinophilic leukemia exhibited cytogenetic changes, including 5q- and monosomy 7.
    • These chromosomal abnormalities are similar to those seen in other secondary acute nonlymphocytic leukemias.
    • The case suggests a link between melphalan treatment and the development of this specific leukemia subtype.

    Implications:

    • This case underscores the potential for rare, chemotherapy-induced leukemias.
    • Understanding these secondary malignancies is crucial for long-term cancer patient management.
    • Further research may elucidate the mechanisms behind chemotherapy-induced eosinophilic leukemia.

    Related Experiment Videos